🔥 Saturday 18 April 2026 Sat, 18 Apr 2026

Speculative growth names and biotech drove the biggest gains this week, while one consumer staple copped the heaviest selling after cutting guidance. Deal flow stayed busy, but investors were even more responsive to hard numbers: profit upgrades, feasibility studies, contract wins and fresh drilling results.

Deal activity and fintech growth set the pace, with Zip surging and Insignia moving closer to leaving the boards. At the same time, regulators kept pressure on insurance deals and several fund managers showed how choppy markets are hitting assets and flows.

Drilling wins, funding deals and takeover activity drove a busy week in materials stocks. Big moves came from early-stage explorers, while larger producers won support with cash flow, mine life and deal-making.

Big gains came from contracts, approvals and takeover interest, while several capital raisings and debt deals drew a cooler response. Diagnostics, radiopharma and medtech led the week, with buyers rewarding companies that showed clear sales, supply or hospital access.

Small-cap tech money chased clear revenue stories, AI products and contract wins this week. The biggest moves came from Xref and ION Video, while BluGlass fell after tapping investors for fresh cash.